Related Experiment Videos
[Intradural ropivacaine for cesarean section: choosing the appropriate dose]
1Departamento de Anestesia, Maternidad del Este, Valencia, Carabobo, Venezuela. gustavosarai2002@yahoo.es
Revista Espanola De Anestesiologia Y Reanimacion
|January 27, 2006
Summary
For cesarean sections, a lower dose of ropivacaine (7.5 mg) resulted in more supplementary doses but less hypotension compared to a higher dose (10 mg). The 10 mg dose provided satisfactory anesthesia but increased hypotension risk.
Area of Science:
- Anesthesiology
- Obstetrics
- Pharmacology
Background:
- Spinal anesthesia trends favor reduced local anesthetic doses.
- Optimizing anesthetic regimens for cesarean delivery is crucial for maternal and fetal outcomes.
Purpose of the Study:
- To compare the efficacy and safety of two minimum doses of ropivacaine administered via intradural infusion for cesarean section.
- To evaluate hemodynamic stability, anesthetic characteristics, and patient satisfaction.
Main Methods:
- A randomized study involving 64 women undergoing cesarean delivery.
- Two groups received either 7.5 mg of 0.75% ropivacaine (ROP 0.75%) or 10 mg of 1% ropivacaine (ROP 1%), both with 25 mcg fentanyl.
- Key parameters included block characteristics, hemodynamic changes, motor function recovery, and adverse events.
Main Results:
- The ROP 0.75% group required supplementary doses in 16% of cases (P<0.05).
- Hypotension incidence was significantly higher in the ROP 1% group (60% vs 28%), with greater ephedrine requirements.
- No significant differences were observed in other assessed parameters.
Conclusions:
- The 7.5 mg ropivacaine dose (ROP 0.75%) led to a higher need for supplementary anesthesia but a lower incidence of hypotension.
- While the 10 mg dose (ROP 1%) provided satisfactory anesthesia, it was associated with a greater risk of hypotension.